ClinTex CTi (CTI)

ClinTex CTi (CTI) is a blockchain-based coin that aims to revolutionize the clinical trials industry. Currently, inefficiencies in clinical trials are costing millions of dollars per day and causing significant delays in delivering new medicine to needy patients. ClinTex seeks to address these issues by providing a software platform called Clinical Trials Intelligence, which incorporates predictive analytics, machine learning, and the innovative use of blockchain technology and smart contracts. Their mission is to reduce development costs for the pharmaceutical industry, bringing down the cost of medicine and improving the speed at which new medicines are marketable.

Clinical Trials Intelligence is a distributed technology platform that uses data analytics, machine learning, and smart contracts to drive operational improvements in clinical trials. Through powerful data analytics functionality, stakeholders can identify and resolve potential issues before they negatively impact the trial. The platform facilitates collaboration across the pharmaceutical industry while addressing privacy and security concerns. With advanced workflow management and an immutable audit trail provided by blockchain technology, pharmaceutical companies can gain deep insights into their trials without major investments in technical infrastructure or data science expertise.

The CTi ecosystem consists of seven separate apps that provide key insights and benefits to stakeholders, such as clinical project managers, physicians, clinical data managers, pharmacovigilance staff, and site monitors. These apps include CTi-OEM for operational oversight, CTi-CDV for enhanced clinical data review, CTi-PDA for predictive analytics, CTi-RBM for risk-based monitoring, CTi-PRR for patient recruitment and retention, CTi-SIM for site investigators, and CTi-VMM for vendor management. ClinTex has assembled a team with expertise in pharmaceuticals, clinical trials, software development, data analytics, and blockchain to drive the development and implementation of Clinical Trials Intelligence.